Facility Monitoring Systems
Facility Monitoring Systems, a specialist in critical monitoring, will be showcasing four new products at 3C.
Among them is the the REMOTE 5104V. Compatible with VHP, this device meets the stringent requirements of today's aseptic processing applications. In addition, the REMOTE 5104V was designed to operate in CLASS 1 DIV 2 hazardous environments found in many challenging applications.
The monitor uses a critical orifice and external vacuum source for flow control. Built-in flow monitoring assures accuracy and reliability of the sensor's performance. With a sensitivity of 0.5 micron and a monitored flow rate of 1.0 CFM (28.3 LPM), the REMOTE 5104V provides real-time continuous data collection at a cost-effective price per point.
The monitor integrates seamlessly with large facility monitoring/management systems and transfers up to four channels of simultaneous particle count data using RS-485 Modbus.
Designed with quality in mind, the REMOTE LPC 0.1µm, 0.2µm and 0.5µm liquid particle counter was created for continuous 24 hour, 7 days a week operation. Following a quality standard of reliability and dependability, Lighthouse developed the REMOTE LPC using thel atest in optical particle counter technology.
With a sensitivity of 0.1, 0.2 and 0.5 microns respectively and a sample flow rate of 100 ml/min, the REMOTE LPC provides real-time continuous data collection at a cost effective price per point. It integrates seamlessly with large facility monitoring/management systems and transfers four channels of simultaneous particle count data using RS-485 Modbus.
'MICROFLOW' has been developed for air biocontaminants sampling in critical places. MICROFLOW allow the verification and quantification of microorganism presence. In this way you can value the exposure or you can identify the source in order to put in place corrective actions.
For the first time, the US FDA has approved the use of ATP bioluminescence for the evaluation of microbial contamination in the pharmaceutical industry. PALLCHEK is the first Rapid Microbiology System, based on ATP bioluminescence, that has successfully and completely met the necessary requirements needed for getting the FDA approval under Process Analytical Technologies (PAT) initiative, as a test method for pharmaceutical product release.
Routine usage of the PALLCHEK Rapid Microbiology System requires only a modest financial investment. It is easy to validate, offering a rapid return of the economical investment.
Visit stand G103 for more details.